Regional brain distribution of [18F]GBR 13119, a dopamine uptake inhibitor, in CD-1 and C57BL/6 mice
- 1 July 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 166 (2), 331-334
- https://doi.org/10.1016/0014-2999(89)90078-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivoInternational Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1989
- Synthesis of [18F]GBR13119, a presynaptic dopamine uptake antagonistInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1988
- In vivo and in vitro autoradiographic labelling of central dopaminergic systems with [3H]GBR12783 in rodentsNeuroscience Letters, 1988
- Time course of MPTP-induced degeneration of the nigrostriatal dopamine system in C57 BL/6 miceBrain Research Bulletin, 1988
- In vivo binding of [18F]GBR 13119 to the brain dopamine uptake systemLife Sciences, 1988
- [3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor siteEuropean Journal of Pharmacology, 1987
- In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatumNeuroscience Letters, 1987
- Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigraBrain Research, 1987
- A SIMPLE QUANTITATIVE BRADYKINESIA TEST IN MPTP-TREATED MICE1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984